Malley Thomas

Average Profitability
3.09%
Insider Buys Quantity
10
Insider Buys Sum
$6.21M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Malley Thomas

The largest purchase of all time was on 2016-11-23 and amounted to 60000 shares of BeiGene, Ltd. for $1.92M.

Biography of Malley Thomas

No biography is available at this moment.

2023-06-16PurchaseKura Oncology, Inc.
KURA
director
50,000
0.0781%
$11.50$575,000+13.75%
2016-11-23PurchaseBeiGene, Ltd.
BGNE
director
60,000
0.1512%
$32.00$1.92M+25.31%
2015-11-10PurchaseKura Oncology, Inc.
KURA
director
100,000
0.9645%
$8.00$800,000-47.54%
2015-04-08PurchaseTempest Therapeutics, Inc.
TPST
director
5,000
0.0183%
$28.50$142,500-50.91%
2015-01-13PurchaseTempest Therapeutics, Inc.
TPST
director
35,000
0.1294%
$50.00$1.75M-44.64%
2013-03-18PurchaseTempest Therapeutics, Inc.
TPST
director
50,000
0.3211%
$9.00$450,000-4.76%
2012-10-24PurchasePuma Biotechnology, Inc.
PBYI
director
20,000
0.0556%
$16.00$320,000+51.73%
2012-06-11PurchasePuma Biotechnology, Inc.
PBYI
director
10,032
0.0501%
$12.50$125,400+72.68%
2012-06-08PurchasePuma Biotechnology, Inc.
PBYI
director
8,168
0.0408%
$12.50$102,100+71.6%
2012-06-07PurchasePuma Biotechnology, Inc.
PBYI
director
1,800
0.009%
$12.50$22,500+70.88%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.